Patients with hemoglobin A@c ( HbA@c ) of @-@ @ % on diet therapy were randomized in a double-blind manner to treatment with @ , @ , @ , or @mg luseogliflozin or placebo for @ weeks ( n = @ , @ , @ , @ , and @ , respectively ) .